They found HOXA9 and RASSF1A to have higher methylation levels in SCLC than NSCLC among 129 samples, displaying relatively high specificity and accuracy (>79%) but modest sensitivity (63.9% and 52.0%, respectively). The gene discussed is HOXA9; the disease is non-small cell lung carcinoma.